Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03101748
Title 3HT With Taxol for Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

breast cancer

Therapies

Neratinib + Paclitaxel + Pertuzumab + Trastuzumab

Cyclophosphamide + Doxorubicin + Neratinib + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.